fbpx
Living with Lupus

Direct-To-Family (Decentralized) Clinical Trials

Living with Lupus

What is Autoimmune Hypophysitis?

Autoimmune hypophysitis is a chronic inflammation of the pituitary gland that can...

Living with Lupus

Platelet Counts, Thrombocytopenia, and Lupus

Lupus can have far reaching impacts throughout the body. Low platelet count,...

Diagnosis

AI, Machine-Based Learning Software, and Lupus

Will artificial intelligence help us better understand lupus? The answer is yes, through the process of machine learning. (Powered by the correct data of course) “Machine learning” is a term for a type of artificial intelligence or “AI” that adapts and changes how it...

Diagnosis and Tests

FDA Approves Aurinia Pharmaceuticals’ LUPKYNIS for Adult Patients with Active Lupus Nephritis

LUPKYNIS (voclosporin) is the first FDA-approved oral therapy for lupus nephritis, a condition that causes irreversible kidney damage and increases the risk of kidney failure, cardiac events, and death. On Monday, January 25, 2021, Aurinia Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) approved LUPKYNIS (voclosporin) to...

Federal Assistance

Hospital Readmission and Severe Lupus Disease Activity

Life with lupus can feel like a revolving door -- between your home, your rheumatologist's office, and the hospital. There are many costs associated with hospital readmission, including lost time and risk of catching a disease. So, how can Lupus Warriors and hospitals work together to avoid...

Diagnosis and Tests

New Lab Test Identifies Lupus Flare Risk 12 Weeks in Advance

New blood test, aiSLE™ DX Flare Risk Index, identifies lupus flare risk up to 12 weeks in advance. The lab test is now available for clinical use. Note: Progentec Diagnostics, Inc., the company that developed aiSLE™ DX Flare Risk Index, also powers LupusCornerLife with lupus comes...

Day-to-Day Living

Coronavirus and Lupus | Things to Know

Coronavirus, also known as COVID-19, is a respiratory disease related to the common cold. Although most healthy people do not need to worry about the disease, people with lupus should be careful. This disease has been in the news lately, and COVID-19 (short for Coronavirus disease 2019) may well be...

Medications

Cenerimod: A Potential New Lupus Medication

Research is underway to measure the effectiveness of Cenerimod, a new lupus medication. Early evidence suggests it can help reduce symptoms and prevent flares. Cenerimod is a new medication being developed by the company Idorsia. It is an agonist and modulator for the

Federal Assistance

NIH Funding and Lupus

The National Institute of Health, or NIH, is a part of the federal government that is responsible for funding, facilitating, and conducting research that improves the health of the nation and the world. Autoimmune diseases, including lupus, are a major health problem for the American people. Because of...

Research

What is the World Health Organization?

The World Health Organization is an international organization dedicated to improving the health of people all over the world through education, aid work, & research. Who is the WHO? (For once, I'm not talking about the rock opera writing, legendary band!) The World...

Medications

TULIP 2 Phase III and Type 1 Interferon Lupus Treatments

Anifrolumab, a promising type 1 interferon medication, passed its second Phase III trial. The new treatment is now eligible for approval for the treatment of lupus. Type 1 interferon medications are promising candidates for treating lupus because they reduce inflammation and temper...